Furthermore, the anticancer mechanism of azurin, attributed to its preferential entry into cancer cells (often mediated by the p28 domain) and its interaction with key eukaryotic regulatory proteins such as p53 [22,26], is distinct from its physiological role in bacterial metabolism. The gene discussed is TP53; the disease is cancer.